Zhitong Finance App News, Sinopharm Hyundai (600420.SH) issued an announcement. Recently, Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. (hereinafter referred to as Sinopharm Rongsheng), a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” for bumetanib injections approved and issued by the China Drug Administration.

Zhitong Finance App News, Sinopharm Hyundai (600420.SH) issued an announcement. Recently, Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. (hereinafter referred to as Sinopharm Rongsheng), a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” for bumetanib injections approved and issued by the China Drug Administration.